Some inhibitors of purine nucleoside phosphorylase

[1]  A. Bzowska,et al.  Synthesis and biological evaluation of 9-deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid as multi-substrate analogue inhibitors of PNP. , 2007, Bioorganic & medicinal chemistry letters.

[2]  A. Bzowska,et al.  SPECTROSCOPIC AND KINETIC STUDIES OF INTERACTIONS OF CALF SPLEEN PURINE NUCLEOSIDE PHOSPHORYLASE WITH 8-AZAGUANINE, AND ITS 9-(2-PHOSPHONYLMETHOXYETHYL) DERIVATIVE , 2005, Nucleosides, nucleotides & nucleic acids.

[3]  A. Bzowska,et al.  Interactions of Calf Spleen Purine Nucleoside Phosphorylase with 8-Azaguanine, and a Bisubstrate Analogue Inhibitor: Implications for the Reaction Mechanism , 2004, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[4]  A. Ray,et al.  Role of Purine Nucleoside Phosphorylase in Interactions between 2′,3′-Dideoxyinosine and Allopurinol, Ganciclovir, or Tenofovir , 2004, Antimicrobial Agents and Chemotherapy.

[5]  S. Bantia,et al.  Purine nucleoside phosphorylase inhibitors in T-cell malignancies. , 2004, Current opinion in drug discovery & development.

[6]  J. H. Pereira,et al.  Structural basis for inhibition of human PNP by immucillin-H. , 2003, Biochemical and biophysical research communications.

[7]  Walter Filgueira de Azevedo,et al.  Crystal structure of human purine nucleoside phosphorylase complexed with acyclovir. , 2003, Biochemical and biophysical research communications.

[8]  G. Evans,et al.  Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase. , 2003, Journal of medicinal chemistry.

[9]  S. Bantia,et al.  Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777. , 2003, International immunopharmacology.

[10]  B. Kierdaszuk,et al.  Xanthosine and xanthine. Substrate properties with purine nucleoside phosphorylases, and relevance to other enzyme systems. , 2002, European journal of biochemistry.

[11]  D Shugar,et al.  Purine nucleoside phosphorylases: properties, functions, and clinical aspects. , 2000, Pharmacology & therapeutics.

[12]  S. P. Walton,et al.  Synthesis and Biological Activity of a Novel Class of Purine Nucleoside Phosphorylase Inhibitors , 2000, Nucleosides, nucleotides & nucleic acids.

[13]  V. Farutin,et al.  Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase. , 1999, Journal of medicinal chemistry.

[14]  A. Bzowska,et al.  SUBSTRATE/INHIBITOR PROPERTIES OF TUMOUR PURINE NUCLEOSIDE PHOSPHORYLASE , 1995 .